Skin Cancer & Melanoma

Latest News

Second-line end points of the TRICOTEL trial assessing atezolizumab plus vemurafenib and cobimetinib in melanoma with central nervous system metastases appear consistent with primary efficacy end points.
Atezolizumab Combo Results in Intracranial Activity in BRAFV600+ Melanoma

September 7th 2023

Second-line end points of the TRICOTEL trial assessing atezolizumab plus vemurafenib and cobimetinib in melanoma with central nervous system metastases appear consistent with primary efficacy end points.

Adjuvant Nivolumab Earns European Approval in Resected Stage IIB/C Melanoma | Image Credit: © David A Litman - stock.adobe.com.
Adjuvant Nivolumab Earns European Approval in Resected Stage IIB/C Melanoma

August 24th 2023

Supporting data for the FDA approval of melphalan administered via percutaneous hepatic perfusion for metastatic uveal melanoma come from the phase 3 FOCUS study.
FDA Approves Melphalan Injection in Hepatic-Dominant Uveal Melanoma

August 15th 2023

Using the 31-gene expression profile assay may help lead to more personalized treatment strategies in patients with cutaneous melanoma, according to Aaron Farberg, MD.
31-GEP Assay May Help to Extend Survival in Cutaneous Melanoma

August 7th 2023

Cosibelimab Yields Enduring Responses in Metastatic/Advanced Cutaneous SCC | Image Credit: © royalstockphoto - stock.adobe.com.
Cosibelimab Yields Enduring Responses in Metastatic/Advanced Cutaneous SCC

July 31st 2023

Video Series
Video Interviews
Podcasts
OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma
On this episode of CancerNetwork’s podcast, Emily Smith, MD, discussed a patient case of basal cell carcinoma she and colleagues published in the journal ONCOLOGY.
Latest CME Events & Activities

More News